Phendimetrazine Alternatives Compared
Phendimetrazine | Wegovy (semaglutide) | Semaglutide |
|
---|
Phendimetrazine | Wegovy (semaglutide) | Semaglutide |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Weight Loss (Obesity/Overweight). Phendimetrazine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Weight Loss (Obesity/Overweight), Cardiovascular Risk Reduction, Nonalcoholic Steatohepatitis. Wegovy may also be used for purposes not listed in this medication guide. |
Prescription only
Semaglutide (Ozempic, Rybelsus) lowers blood sugar levels by mimicking the effects of GLP-1, a naturally occurring hormone that stimulates insulin secretion and lowers glucagon secretion from the... View more |
Related suggestions Weight Loss (Obesity/Overweight)
|
|||||||
More about Phendimetrazine | More about Wegovy (semaglutide) | More about Semaglutide | ||||||||
Ratings & Reviews | ||||||||||
Phendimetrazine has an average rating of 8.2 out of 10 from a total of 155 ratings on Drugs.com. 79% of reviewers reported a positive effect, while 10% reported a negative effect. |
Wegovy has an average rating of 7.5 out of 10 from a total of 529 ratings on Drugs.com. 65% of reviewers reported a positive effect, while 15% reported a negative effect. |
Semaglutide has an average rating of 6.9 out of 10 from a total of 2778 ratings on Drugs.com. 56% of reviewers reported a positive effect, while 20% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Phendimetrazine side effects |
View all Wegovy side effects |
View all Semaglutide side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
Lower cost generic |
N/A |
|||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
View all Phendimetrazine prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
|
|
N/A |
||||||||
Brand Names | ||||||||||
Bontril PDM | Other semaglutide brands include: Ozempic, Rybelsus | Ozempic, Rybelsus, Wegovy | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
3.7 hours |
168 hours |
168 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 174 drugs are known to interact with Phendimetrazine:
|
A total of 275 drugs are known to interact with Wegovy:
|
A total of 275 drugs are known to interact with Semaglutide:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
|
||||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
October 20, 1975 |
N/A |
December 05, 2017 |
||||||||
WADA Class View classifications | ||||||||||
N/A |
N/A |
|||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.